BDX : Analysis & Opinions

  1. MedTech Industry Stock Update - Sept 2013 - Industry Outlook

    September 10, 2013
    MedTech Industry Stock Update - Sept 2013 - Industry Outlook
  2. Patterson Stays at Neutral - Analyst Blog

    July 5, 2013
    We retained our Neutral recommendation on Patterson following its modest fourth-quarter fiscal 2013 results.
  3. CONMED Retained at Neutral - Analyst Blog

    July 5, 2013
    We reiterated our Neutral recommendation on CONMED following its moderate first-quarter results.
  4. ViroPharma and Other Biotech Stocks Recommended by Oppenheimer ...

    June 24, 2013
    Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new ...
  5. Cooper Hits 52-Week High - Analyst Blog

    June 18, 2013
    The Cooper Companies Inc. attains a 52-week high of $122.80 on Monday, June 17.
  6. Mindray to Takeover ZONARE - Analyst Blog

    June 17, 2013
    Mindray Medical International Limited recently reported a definitive agreement to takeover ZONARE Medical Systems, Inc.
  7. Cooper Unveils MyDay Lenses - Analyst Blog

    June 10, 2013
    CooperVision recently introduced the MyDay daily disposable contact lenses to the British Contact Lens Association (BCLA) ...
  8. Top-Performing Dividend Payers in Health Care with the Most Upside ...

    June 8, 2013
    It is not unusual for stocks on a tear to overrun their mean price targets, which is a signal of how far analysts on average ...
  9. Investing For The Global Diabetes Epidemic

    May 31, 2013
    Sadly, diabetes is quickly becoming a global epidemic. Within these grim statistics, investors can find opportunities with ...
  10. Recent Financials May Not Be Entirely Fair To Hologic

    May 8, 2013
    Macro pressures are outweighing solid internal progress at Hologic.
  11. CONMED Beats 4Q Estimates - Analyst Blog

    February 15, 2013
    CONMED Corporation (CNMD), a medical technologies and surgical devices company, reported fourth-quarter 2012 adjusted earnings ...
  12. Reiterate Cerner at Neutral - Analyst Blog

    February 12, 2013
    On Feb 7, we retained Cerner Corporation (CERN), a leading healthcare information technology ("HCIT") solutions provider, ...
  13. Reiterate PerkinElmer at Neutral - Analyst Blog

    February 12, 2013
    On Feb 7, we retained PerkinElmer (PKI) at Neutral after the company met Zacks Consensus Estimate for earnings but missed ...
  14. Cerner Beats Ests, Profit Rises - Analyst Blog

    February 6, 2013
    Leading healthcare information technology ("HCIT") solutions provider Cerner Corporation (CERN) reported fourth-quarter and ...
  15. Cardinal Health: Set to Beat - Analyst Blog

    February 4, 2013
    We expect Cardinal Health (CAH) to beat expectations when it reports fiscal second quarter 2013 results on Feb 5.  Why ...
  16. Life Technologies: Preview - Analyst Blog

    February 4, 2013
    Life Technologies (LIFE) is scheduled to report its fourth-quarter and fiscal 2012 results on Monday, Feb 4, 2013, after ...
  17. CR Bard Squarely Beats Estimates - Analyst Blog

    February 1, 2013
    CR Bard Inc.'s (BCR) fourth-quarter 2012 adjusted earnings of $1.70 per share beat the Zacks Consensus Estimate of $1.67 ...
  18. Earnings Preview: CR Bard Inc. - Analyst Blog

    January 30, 2013
    CR Bard Inc. (BCR) is set to report its fourth-quarter 2012 results after the market closes on Thursday, Jan 31. Let's see ...
  19. Baxter EPS Meets, Profit Inches Up - Analyst Blog

    January 24, 2013
    Baxter International Inc. (BAX) reported fourth quarter and 2012 adjusted (excluding one-time items) earnings per share of ...
  20. Earnings Preview: Covidien - Analyst Blog

    January 23, 2013
    Health care products major Covidien plc (COV) is scheduled to release its third-quarter fiscal 2012 results before trading ...
  21. Covidien Wins FDA Approval - Analyst Blog

    January 22, 2013
    International health care product major, Covidien plc. (COV) recently revealed approval from the Food and Drug Administration ...
  22. Intuitive Preview: Set to Beat - Analyst Blog

    January 21, 2013
    We expect Intuitive Surgical (ISRG) to beat expectations when it reports fourth quarter 2012 results on January 22.  Why ...
  23. FDA Categorizes Cepheid's New Test - Analyst Blog

    January 16, 2013
    Cepheid's (CPHD) Xpert CT/NG test has been recently categorized as 'Moderate Complexity' under the Clinical Laboratory Improvement ...
  24. Covidien Begins SWIFT PRIME Study - Analyst Blog

    January 15, 2013
    International health care product major, Covidien plc. (COV), has initiated a new study, SWIFT PRIME. The main objective ...
  25. Covidien Closes CV Ingenuity Buyout - Analyst Blog

    January 11, 2013
    Large-cap medical technologies company, Covidien plc. (COV) has successfully completed the acquisition of Fremont, California-based ...
  26. Covidien Remains at Neutral - Analyst Blog

    December 28, 2012
    We have reiterated our Neutral recommendation on leading health care products maker, Covidien plc. (COV), with a target price ...
  27. Covidien to Acquire CV Ingenuity - Analyst Blog

    December 27, 2012
    Large-cap medical technologies company, Covidien plc. (COV) has entered into a definitive agreement to acquire Fremont, California-based ...
  28. COV Presents Positive Study Results - Analyst Blog

    December 21, 2012
    Covidien plc. (COV), a large-cap healthcare products company, has announced the five-year results of the ClosureFAST Long-Term ...
  29. BAX Ticks Higher on Buyout Hunch - Analyst Blog

    November 26, 2012
    Baxter International (BAX) is holding talks to acquire Sweden-based medical technology company Gambro AB for about $4 billion, ...
  30. Covidien's 4Q Beats Estimates - Analyst Blog

    November 9, 2012
    Covidien plc. (COV), a large-cap medical technology company, reported its adjusted earnings per share (from continuing operations) ...
  31. Hologic Grows Diagnostics Portfolio - Analyst Blog

    October 17, 2012
    Hologic (HOLX), a prominent player in the women's healthcare market, has expanded its diagnostics portfolio. The company ...
  32. CareFusion to Buy Brazilian Co. - Analyst Blog

    October 9, 2012
    Medical technology company CareFusion (CFN) recently announced an agreement for the acquisition of privately-owned Brazilian ...
  33. COV to Acquire CNS Therapeutics - Analyst Blog

    September 25, 2012
    Recently, Mallinckrodt, the Pharmaceuticals business of Covidien plc (COV), announced a definitive deal to acquire St. Paul ...
  34. Covidien Hikes Dividend - Analyst Blog

    September 24, 2012
    Covidien plc. (COV), a leading health care products company, recently announced a 16% hike in its quarterly dividend to 26 ...
  35. FDA Clears Meridian Ilumigene GAS - Analyst Blog

    September 20, 2012
    Diagnostic test kit maker Meridian Bioscience (VIVO) won the approval of the U.S. Food and Drug Administration (FDA) for ...
  36. Covidien Unveils Vascular Products - Analyst Blog

    September 19, 2012
    Covidien plc. (COV), a leading health care products company, recently introduced the Viance Crossing Catheter and Enteer ...
  37. Covidien Issues FY13 Guidance - Analyst Blog

    September 14, 2012
    At a recent investor's meet, leading health care products company, Covidien plc. (COV) provided its guidance for fiscal 2 ...
  38. Covidien's LigaSure Label Expands - Analyst Blog

    September 12, 2012
    Leading health care products company, Covidien plc. (COV) recently received 510(k) approval from the U.S. Food and Drug Administration ...
  39. CareFusion Awards Best Hospitals - Analyst Blog

    September 11, 2012
    Medical technology company CareFusion (CFN) recently revealed that it recognized 1,187 U.S.-based hospitals for winning a ...
  40. FDA Approval for Covidien's iDrive - Analyst Blog

    August 31, 2012
    Leading health care products company, Covidien plc. (COV) recently received 510(k) approval from the U.S. Food and Drug Association ...
  41. FDA Clears Covidien's Exalgo Tablet - Analyst Blog

    August 28, 2012
    Mallinckrodt, the pharmaceuticals business of Covidien plc (COV), recently received the clearance of the U.S. Food and Drug ...
  42. Product Recall Woes for CareFusion - Analyst Blog

    August 24, 2012
    Recently, CareFusion (CFN), a medical technology company, announced the voluntary recall of its Alaris Pump Module, Model ...
  43. Slew of Product Recalls at Covidien - Analyst Blog

    August 24, 2012
    Recently, health care products major Covidien plc. (COV) has been hit by a number of product recalls, the most significant ...
  44. Covidien Backs Safe Use of Opioid - Analyst Blog

    August 17, 2012
    Leading medical instruments and supplies company Covidien plc. (COV) has extended its support for the recently announced ...
  45. Covidien Remains Neutral Post-Earnings - Analyst Blog

    August 13, 2012
    We reiterate our Neutral recommendation on Covidien plc. (COV). The company's adjusted earnings per share (from continuing ...
  46. Covidien Opens R&D Base in China - Analyst Blog

    August 6, 2012
    Leading healthcare products maker Covidien plc. (COV) recently announced the inauguration of its latest Research and Development ...
  47. Mixed 3Q for Covidien, Profit Drops - Analyst Blog

    July 26, 2012
    Covidien plc (COV), a large-cap medical technology company, reported its adjusted earnings per share (from continuing operations) ...
  48. CareFusion Updates on EnVe Recall - Analyst Blog

    July 18, 2012
    Medical technology company CareFusion (CFN) has provided further updates regarding the earlier announced voluntary recall ...
  49. Software for Covidien's ForceTriad - Analyst Blog

    July 16, 2012
    Leading healthcare products maker Covidien (COV) recently announced a new software application for its ForceTriad energy ...
  50. Covidien Completes Oridion Buyout - Analyst Blog

    June 27, 2012
    Leading health care products maker Covidien (COV) recently completed its takeover of Israel-based medical devices firm Oridion ...
  51. Gen-Probe-Hologic Deal Moves Ahead - Analyst Blog

    June 22, 2012
    In relation to its acquisition by Hologic Inc. (HOLX), Gen-Probe Inc. (GPRO) revealed that the federally required 30-day ...
  52. Bio-Reference Labs Taking Advantage Of Esoteric Opportunities

    June 22, 2012
    The decision of whether to buy Bio-Reference really comes down to an investor's confidence in the growth prospects for the ...
  53. Covidien Launches V-Loc - Analyst Blog

    June 20, 2012
    On June 19, Covidien plc (COV), a global leader in medical devices and services, launched the world's first knotless suturing ...
  54. Medical Action Reports Loss - Analyst Blog

    June 18, 2012
    On June 14, Medical Action Industries (MDCI), a manufacturer and distributer of medical and surgical disposable products, ...
  55. Covidien Promotes Zogenix's Product - Analyst Blog

    June 8, 2012
    The pharmaceutical unit of Covidien plc (COV) and Zogenix Inc. (ZGNX) have recently agreed to co-endorse a prescription medicine ...
  56. Covidien Makes a Philanthropic Move - Analyst Blog

    June 7, 2012
    Leading global health care products company, Covidien plc (COV), has offered its support to a non-governmental organization ...
  57. COV Launches Endo GIA Radial Reload - Analyst Blog

    June 2, 2012
    Covidien plc (COV), a large-cap medical technology company, launched its latest offering, the Endo GIA Radial Reload aided ...
  58. CareFusion: Is It Still Cheap?

    May 3, 2012
    The biggest concern investors have with CareFusion is its low return on invested capital. Until it creates higher free cash ...
  59. Modest But Predictable Growth At C.R. Bard

    April 26, 2012
    C.R. Bard is posting modest operational growth but there is ample downside protection.
  60. Fundamentals Point to 7 Dividend Payers

    February 24, 2012
    Accelerating dividend payments are among the fundamental metrics fund manager Robert Zagunis tracks in his stock-selection ...
  61. A Pause In Electronic Test Gives Investors Another Chance With ...

    February 17, 2012
    Agilent pauses with the telecom slowdown.
  62. Will Qiagen's Restructuring Address The Real Problems?

    November 30, 2011
    Will Qiagen's Restructuring Address The Real Problems?
  63. Covidien Delivers Once Again

    November 21, 2011
    Covidien is overlooked and undervalued.
  64. Meridian Biosciences – Stealth Income Play

    November 16, 2011
    Meridian offers an impressive dividend, but a high valuation as well.
  65. Is Hologic A Coiled Spring?

    November 11, 2011
    Hologic looks cheap on even modest growth recovery expectations.
  66. Hologic Holding Its Place

    August 8, 2011
    Hologic's volume is not great today, but business should improve more than the market currently believes.
  67. Covidien's Image Starting To Change

    August 3, 2011
    Find out why Covidien is much better than many investors assume.
  68. Cepheid Soaring

    August 2, 2011
    Cepheid is becoming a real player in MDx, but the valuation is way ahead.
  69. Danaher Hopes To Revive Beckman Coulter

    February 9, 2011
    Learn more about Danaher's expensive, albeit strategic, bid for a leading diagnostics franchise.
  70. Qiagen Hopes To Ride MDx

    November 11, 2010
    Qiagen doesn't seem to be earning the healthy esteem Wall Street has for the stock.
  71. With Minimal Expectations, Hologic Could Still Surprise

    November 10, 2010
    Hologic is suffering from low expectations, but value investors may have a bargain here.
  72. Abbott Labs Showing Meaningful Growth

    October 21, 2010
    Abbott might just be the best healthcare stock today.
  73. Money To Be Made In Medical Devices

    September 22, 2010
    New advances in medical devices will not only help patients live better lives, but they'll power portfolios as well.
  74. Still Time To Buy Hologic

    August 5, 2010
    Hologic is still suffering from the economy, but more profitable days should lie ahead.
  75. Investing For The Diabetes Epidemic

    July 30, 2010
    Sadly, diabetes is quickly becoming a global epidemic. Nearly 300 million people suffer from the disease worldwide.
  76. Great Dividend Payers In Medical Technology

    May 21, 2010
    Dividend-paying stocks are not common in medical technology, but these four proven winners deliver the goods.
  77. Covidien Proving Instrumental To Healthcare Providers

    April 27, 2010
    Covidien stands out from rivals for its potential to increase efficiencies and wring out further costs after its separation ...
  78. Time To Buy Baxter

    April 13, 2010
    Despite poor stock performance malaise, Baxter's sales and earnings growth have remained impressive.
  79. A Mixed Bag At Teleflex

    March 1, 2010
    Teleflex's recent decision to emphasize medical devices and supplies has yet to pay off for shareholders.
  80. Baxter: Just What the Doctor Ordered

    July 28, 2009
    Although Baxter shares have been cheaper, at it's current valuation, this stock might still be just what the doctor ordered.
  81. Baxter A Healthy Healthcare Holding

    April 22, 2009
    Baxter's recent results demonstrate why it continues as a leader in its industry and should be considered a core healthcare ...
  82. Five Socially Responsible Stocks For July 14

    July 14, 2008
    Sustainable businesses can present an opportunity to generate profits through a socially responsible investment.
  83. Booster Shot Needed (BSX, BDX)

    July 6, 2007
    A look at two medical technology companies who make "must have" products, yet struggle to find success.
  84. As Good As New (BDX, BSX, ZMH)

    May 11, 2007
    A look at several companies poised to meet the healthcare needs of the aging baby-boomer generation
  85. Winners and Losers - August 14th - 18th (TPTH, RBAK, MODT, MED)

    August 18, 2006
    A look at the winners and losers for the week of August 14th.
Investing News
  1. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  2. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  3. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  4. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  5. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
  6. Can Paying Off Your Mortgage Early Hurt Your Net Worth?

    Saving your money and making double or even triple payments on a mortgage may sound productive, ...
Trading Center